Atopic dermatitis, also known as eczema, is a chronic, inflammatory skin condition characterized by intense itching, dry skin, and recurrent flare-ups of red, inflamed lesions. It is driven by a ...

Shastry is an assistant professor of dermatology at Northwestern Feinberg School of Medicine in Chicago. The information here represents her knowledge and experience as a medical professional. She was ...

The atopic dermatitis market offers opportunities in developing new and innovative therapies, with over 100 companies and 110 drugs in various stages of development. Key areas include novel biologic ...

In an update to the guidelines for managing atopic dermatitis in adults, four new treatment recommendations are presented. The focused update was published online in the Journal of the American ...

Most people with atopic dermatitis (a type of eczema) are able to control their symptoms by using topical treatments that are applied to the skin. But for some people with severe atopic dermatitis, ...

A safety update for abrocitinib has shown the drug to be safe out to nearly 4 years for the treatment of moderate-to-severe atopic dermatitis (AD). The risk of adverse events (AE) increased for ...

Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for targeted treatments and achieving long-term remission. Raj Chovatiya, MD, ...

“Decision-making is a critical component of health care delivery, but the number of therapies available can be overwhelming to patients, preventing them from making fully informed care decisions,” the ...